Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion type Assertion NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_head.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_provenance.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion evidence source_evidence_literature NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_provenance.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion SIO_000772 20664061 NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_provenance.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion wasDerivedFrom befree-20150227 NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_provenance.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion wasGeneratedBy ECO_0000203 NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_provenance.